DB12330InvestigationalProtein Based Therapies
Blisibimod has been used in trials studying the treatment of IgA Nephropathy, Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Granulomatosis With Polyangiitis.
- Mechanism
- Curator reviewed
Pharmacologically active on Tumor necrosis factor ligand superfamily member 13B
- Code names
- A-623
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
Which drugs share a target with Blisibimod, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account